Regeneron Pharmaceuticals Inc (REGN)
661.14
+3.99 (+0.61%)
USD |
NASDAQ |
May 20, 16:00
661.00
-0.14 (-0.02%)
After-Hours: 20:00
Regeneron Pharmaceuticals PE Ratio: 9.365 for May 20, 2022
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| May 20, 2022 | 9.365 |
| May 19, 2022 | 9.308 |
| May 18, 2022 | 9.337 |
| May 17, 2022 | 9.456 |
| May 16, 2022 | 9.278 |
| May 13, 2022 | 9.143 |
| May 12, 2022 | 8.980 |
| May 11, 2022 | 8.683 |
| May 10, 2022 | 8.712 |
| May 09, 2022 | 8.495 |
| May 06, 2022 | 8.825 |
| May 05, 2022 | 9.056 |
| May 04, 2022 | 9.361 |
| May 03, 2022 | 9.355 |
| May 02, 2022 | 9.235 |
| April 29, 2022 | 9.336 |
| April 28, 2022 | 9.569 |
| April 27, 2022 | 9.540 |
| April 26, 2022 | 9.558 |
| April 25, 2022 | 9.778 |
| April 22, 2022 | 9.746 |
| April 21, 2022 | 10.00 |
| April 20, 2022 | 10.19 |
| April 19, 2022 | 10.14 |
| April 18, 2022 | 10.24 |
| Date | Value |
|---|---|
| April 14, 2022 | 10.38 |
| April 13, 2022 | 10.37 |
| April 12, 2022 | 10.14 |
| April 11, 2022 | 10.23 |
| April 08, 2022 | 10.47 |
| April 07, 2022 | 10.22 |
| April 06, 2022 | 10.03 |
| April 05, 2022 | 9.794 |
| April 04, 2022 | 9.892 |
| April 01, 2022 | 9.842 |
| March 31, 2022 | 9.893 |
| March 30, 2022 | 9.606 |
| March 29, 2022 | 9.690 |
| March 28, 2022 | 9.620 |
| March 25, 2022 | 9.434 |
| March 24, 2022 | 9.431 |
| March 23, 2022 | 9.284 |
| March 22, 2022 | 9.609 |
| March 21, 2022 | 9.617 |
| March 18, 2022 | 9.516 |
| March 17, 2022 | 9.506 |
| March 16, 2022 | 9.406 |
| March 15, 2022 | 9.239 |
| March 14, 2022 | 9.107 |
| March 11, 2022 | 8.915 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS (ttm). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
8.256
Minimum
Jan 05 2022
63.36
Maximum
Jun 22 2017
22.47
Average
20.01
Median
Feb 26 2019
PE Ratio Benchmarks
| Vertex Pharmaceuticals Inc | 27.22 |
| Moderna Inc | 4.004 |
| Pfizer Inc | 12.03 |
| Johnson & Johnson | 23.85 |
| Eli Lilly and Co | 44.87 |
PE Ratio Related Metrics
| PS Ratio | 4.518 |
| PEG Ratio | 0.0938 |
| Price to Book Value | 3.647 |
| Price to Free Cash Flow | 9.397 |
| Price | 661.14 |
| Earnings Yield | 10.68% |
| Market Cap | 72.62B |
| PEGY Ratio | 0.0938 |
| Operating PE Ratio | 8.177 |
| Normalized PE Ratio | 9.334 |